Review
Copyright ©The Author(s) 2015.
World J Transplant. Dec 24, 2015; 5(4): 154-164
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.154
Table 3 Selected clinical studies involving renal preservation solutions
Ref.SolutionCasesPatient survivalGraft survival
UW solution vs HTK solution
Lynch et al[60]UW vs HTKLiving donor = 950 (UW 475, HTK 475)No diff (1 yr)No diff (1 yr)
Deceased donor = 634(living or deceased donors)(Living or deceased donors)
(UW 317, HTK 317)
de Boer et al[61]UW vs HTK611 (UW 297, HTK 314)----No diff (1 yr)
(UW 81%, HTK 83%)
Klaus et al[62]UW vs HTK51 (UW 27, HTK 24)No diff (1 yr)No diff (1 yr)
(UW 84% vs HTK 86%)(UW 78%, HTK 79%)
UW solution vs CEL solution
Montalti et al[64]UW vs CEL50 (UW 25, CEL 25)No diff (1 yr)No diff (1 yr)
(UW 100%, CEL 100%)(UW 96%, CEL 91.8%)
P value not stated
Faenza et al[23]UW vs CEL187 (UW 88, CEL 99)No diff (2 yr)No diff (2 yr)
(UW 100%, CEL 100%)(UW 75%, CEL 84%)
P value not stated
Pedotti et al[54]UW vs CEL441 (UW 269, CEL 172)No diff (1 yr)No diff (1 yr)
(UW 97.7%, CEL 99.4%)(UW 91%, CEL 94.2%)
P value not statedP value not stated
EC solution vs HTK solutions
de Boer et al[61]EC vs HTK569 (EC 277, HTK 292)----No diff (1 yr)
(EC 78%, HTK 80%)
P value not stated